Market Highlights
Benzodiazepines (BZD) are a class of
psychoactive drugs with sedative, hypnotic (sleep-inducing), anti-anxiety,
anticonvulsant, and muscle relaxant properties. Benzodiazepines (BZD) are
useful in treating anxiety, insomnia, agitation, seizures, muscle spasms and
alcohol withdrawal.
The
sale of Benzodiazepine has been declining due to their addictive side effects
and the rise of alternate drugs such as selective serotonin reuptake
inhibitors. However the last few years have witnessed a moderate rise in the
sale of Benzodiazepines. The lack of efficacy and slow onset of action of
selective serotonin reuptake inhibitors along with the fear of falling back on
first generation anti-psychotic (barbiturate class) drugs have negated any
market moves against Benzodiazepines. Development of short acting
Benzodiazepines is an additional advantage in favour of barbiturates.
Some
more restraints hampering the market growth are highly competitive and
segmented market and a shift towards non-pharmacological therapies.
Global Benzodiazepine market:
The Global Benzodiazepine market has been
evaluated as a slowly growing market and it is expected that the market will
reflect sluggish growth figures in future. The global Benzodiazepine market is
expected to grow with CAGR of ~ 1.5% to 2.3 % during the
forecast period.
The
major participants of this market are: AstraZeneca plc, Eli Lilly and
Company, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A. and Merck &
Co., Inc.
Regional Analysis:
Depending on geographic region,
Benzodiazepine market is segmented into four key regions: Americas, Europe,
Asia Pacific, and Middle East & Africa. Globally developed countries led by
North America is the largest market for Benzodiazepines. Europe is the
second-largest market for Benzodiazepines. Asia pacific region is expected to
be fastest growing region in Benzodiazepine market due to increasing spending
on healthcare infrastructure.
Segmentation:
Global Benzodiazepines market has been
segmented on the basis of application which comprises of disposable, reusable
and others. On the basis of application; market is segmented into anxiety,
insomnia, agitation, seizures, muscle spasms and alcohol withdrawal and as
anaesthesia supplements. On the basis of time of action; market is segmented
into long acting and short acting Benzodiazepines.
No comments:
Post a Comment